Top Funds / PERCEPTIVE ADVISORS LLC


Joseph Edelman

2019Q1 Portfolio

SEC 13F Filing

Position #Shares $Value % # vs. 2018Q4 $ vs. 2018Q4
NEUROCRINE BIOSCIENCES INC 3,758,662 $331,138,000 9.34% -849,892 +$15,775,000
AMICUS THERAPEUTICS, INC. 21,639,486 $294,297,000 8.30% +915,062 +$102,596,000
Global Blood Therapeutics, Inc. 5,525,726 $292,476,000 8.25% +100,000 +$69,750,000
ZOGENIX, INC. 3,869,491 $212,860,000 6.01% +79,275 +$74,669,000
AMARIN CORP PLC\UK SPONS ADR 6,540,957 $135,790,000 3.83% +1,665,357 +$71,237,000
Ascendis Pharma A/S SPONSORED ADR 1,113,328 $131,039,000 3.70% +60,681 +$67,996,000
IOVANCE BIOTHERAPEUTICS, INC. 12,235,811 $116,362,000 3.28% -5,300 +$8,029,000
MeiraGTx Holdings plc 6,007,746 $103,513,000 2.92% +1,304,348 +$58,173,000
ARRAY BIOPHARMA INC 4,228,900 $103,101,000 2.91% New +$103,101,000
Blueprint Medicines Corp 1,271,054 $101,748,000 2.87% +413,728 +$58,264,000
Quotient Ltd 10,789,054 $97,209,000 2.74% New +$97,209,000
Mirati Therapeutics, Inc. 1,164,382 $85,349,000 2.41% +1,038,507 +$80,099,000
Retrophin, Inc. 3,054,707 $69,128,000 1.95% -287,331 +$19,346,000
REGENXBIO Inc. 1,145,726 $65,662,000 1.85% +500,000 +$38,768,000
MERIT MEDICAL SYSTEMS INC 1,053,098 $65,113,000 1.84% +103,900 +$12,936,000
ARENA PHARMACEUTICALS INC 1,400,171 $62,770,000 1.77% New +$62,770,000
Athenex, Inc. 5,096,022 $62,426,000 1.76% No Change +$29,876,000
Crinetics Pharmaceuticals, Inc. 2,587,953 $58,901,000 1.66% No Change -$18,711,000
CymaBay Therapeutics, Inc. 4,212,821 $55,946,000 1.58% +1,750,000 +$36,564,000
Alector, Inc. 1,704,330 $54,896,000 1.55% No Change +$15,390,000
MyoKardia, Inc. 988,511 $51,393,000 1.45% -86,705 -$2,110,000
Invitae Corp 2,171,918 $50,866,000 1.44% +308,512 +$30,257,000
Allogene Therapeutics, Inc. 1,543,790 $44,630,000 1.26% No Change +$3,056,000
VBI Vaccines Inc/BC 23,951,556 $42,633,000 1.20% New +$42,633,000
MOMENTA PHARMACEUTICALS INC 2,875,000 $41,774,000 1.18% +50,000 +$10,642,000